These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2907415)

  • 1. The suppression of blood growth hormone level by somatostatin infusion in patients with active acromegaly.
    Kwok CF; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Oct; 42(4):249-54. PubMed ID: 2907415
    [No Abstract]   [Full Text] [Related]  

  • 2. Homogeneity in the growth hormone-lowering effect of dopamine and somatostatin in acromegaly.
    Oppizzi G; Botalla L; Verde G; Cozzi R; Liuzzi A; Chiodini PG
    J Clin Endocrinol Metab; 1980 Sep; 51(3):616-9. PubMed ID: 6106023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of somatostatin on basal levels of plasma growth hormone and insulin in acromegalics: dose-response studies and attempted total growth hormone suppression.
    Christensen SE; Nerup J; Hansen AP; Lundbaek K
    J Clin Endocrinol Metab; 1976 May; 42(5):839-45. PubMed ID: 773950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of somatostatin of plasma levels of glucose, insulin and growth hormone in acromegaly].
    Porzio G; Massara F; Camanni F; Rizzi G; Molinatti GM
    Minerva Med; 1976 Oct; 67(50):3241-2. PubMed ID: 995281
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatostatin sensitivity and growth hormone responses to releasing hormones and bromocryptine in acromegaly.
    Pieters GF; Romeijn JE; Smals AG; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 May; 54(5):942-8. PubMed ID: 6120951
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
    Kelijman M; Williams TC; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC; Oldfield E; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly.
    Giustina G; Reschini E; Peracchi M; Cantalamessa L; Cavagnini F; Pinto M; Bulgheroni P
    J Clin Endocrinol Metab; 1974 May; 38(5):906-9. PubMed ID: 4207370
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Ferrari C; Travaglini P; Ambrosi B; Spada A
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1259-62. PubMed ID: 4196265
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
    Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of somatostatin on abnormal GH response to TRH in primary hypothyroidism.
    Baldini M; Catania A; Orsatti A; Manfredi MG; Motta P; Cantalamessa L
    Exp Clin Endocrinol; 1992; 99(2):80-3. PubMed ID: 1353454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of somatostatin in acromegaly].
    Schaison G; Roger M; Milhaud G
    Nouv Presse Med; 1976 Mar; 5(10):629-32. PubMed ID: 772591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disappearance of plasma growth hormone in acromegaly and protein-calorie malnutrition after somatostatin.
    Pimstone BL; Becker D; Kronheim S
    J Clin Endocrinol Metab; 1975 Jan; 40(1):168-71. PubMed ID: 803512
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences between somatostatin-28 and somatostatin-14 with respect to their biological effects in healthy humans and acromegalics.
    Hadjidakis DJ; Raptis SA; Souvatzoglou A; Karaiskos C; Diamantopoulos EJ; Moulopoulos SD
    Clin Physiol Biochem; 1986; 4(6):372-83. PubMed ID: 2880690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatotropic hormone level in acromegalic patients.
    Schokker RC
    Folia Med Neerl; 1969; 12(1):2-7. PubMed ID: 5768557
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test.
    Mazziotti G; Bonadonna S; Doga M; Patelli I; Gazzaruso C; Solerte SB; De Menis E; Giustina A
    Neuroendocrinology; 2008; 88(4):299-304. PubMed ID: 18617732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
    Samaan NA; Leavens ME; Jesse RH
    J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.